To express the sense of the Senate regarding the Medicare part D prescription drug program.
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Senate amendment submitted
February 2, 2006
View full timeline
Senate amendment submitted
February 2, 2006
Senate amendment not agreed to: Amendment SA 2731 not agreed to in Senate by Yea-Nay Vote. 42 - 54. Record Vote Number: 4.
February 2, 2006
Senate amendment proposed (on the floor): Amendment SA 2731 proposed by Senator Grassley to Amendment SA 2707.
February 2, 2006
Roll call votes on amendments in Senate: Amendment SA 2731 not agreed to in Senate by Yea-Nay Vote. 42 - 54. Record Vote Number: 4.
February 2, 2006
Amendment SA 2731 proposed by Senator Grassley to Amendment SA 2707. (consideration: CR S490-491; text: CR S490-491) To express the sense of the Senate regarding the Medicare part D prescription drug program.
February 2, 2006
Amendment SA 2731 not agreed to in Senate by Yea-Nay Vote. 42 - 54. Record Vote Number: 4.
February 2, 2006
Votes
1 roll call on this amendment
Text
Submitted
SA 2731. Mr. GRASSLEY proposed an amendment to amendment SA 2707 proposed by Mr. Frist (for Mr. Grassley (for himself and Mr. Baucus)) to the bill H.R. 4297, to provide for reconciliation pursuant to section 201(b) of the concurrent resolution on the budget for fiscal year 2006; as follows: At the appropriate place, insert the following: SEC. __. SENSE OF THE SENATE REGARDING THE MEDICARE PART D PRESCRIPTION DRUG PROGRAM. (a) Findings.--The Senate finds the following: (1) It is not acceptable that startup issues under the new Medicare prescription drug program have resulted in some of our Nation's most vulnerable citizens having difficulties getting their prescription drugs covered under the program, and these issues must be addressed and resolved. (2) The Department of Health and Human Services and the Centers for Medicare & [[Page S679]] Medicaid Services are working tirelessly to address these startup issues and have taken numerous steps to smooth the transition process. (3) All prescription drug plans under part D of title XVIII of the Social Security Act and MA-PD plans under part C of such title (in this section referred to as ``Medicare prescription drug plans'') already have a ``first fill'' policy in place that provides a new enrollee with coverage for prescription drugs during at least the first 30 days of enrollment regardless of whether the particular prescription drug is on the plan's formulary, and the Centers for Medicare & Medicaid Services is enforcing this requirement. (4) Under current law, full-benefit dual eligible individuals (as defined in section 1935(c)(6) of the Social Security Act (42 U.S.C. 1395u-5(c)(6)) are already automatically enrolled into Medicare prescription drug coverage so no change in law is necessary. (5) Medicare prescription drug plans are already responsible for covering the cost of covered prescriptions filled for enrollees, including short term transition prescriptions. (6) Medicare prescription drug plans are already responsible for reimbursing any enrollee, including full- benefit dual eligible individuals, for any out-of-pocket costs incurred by the enrollee that should have been covered by the plan. (7) The Centers for Medicare & Medicaid Services is already reimbursing States for the reasonable administrative costs incurred by States that have temporarily covered some claims for prescription drug coverage during the transition period. (8) Enrollment is exceeding projections, with at least 24,000,000 Medicare beneficiaries who now have drug coverage and another 90,000 are enrolling each day in the Medicare prescription drug program; (9) In addition, the Secretary of Health and Human Services has taken many other actions to smooth the implementation of the Medicare prescription drug program, including the following: (A) Establishing processes to ensure that full-benefit dual eligible individuals are not overcharged for their prescriptions and to require Medicare prescription drug plans to refund overcharges to such individuals. (B) Establishing a reconciliation process to ensure that Medicare prescription drug plans reimburse pharmacies for costs incurred by pharmacies that are payable by such plans. (C) Conducting extensive and continuing outreach to pharmacies and pharmacy associations on the implementation of the Medicare prescription drug benefit, particularly with respect to full-benefit dual eligible individuals, as well as establishing a special pharmacy telephone help line. (D) Requiring Medicare prescription drug plans to have comprehensive formularies and procedures for enrollees to rapidly secure an exception to the limitation of coverage of a prescription drug when medical necessity is demonstrated. (E) Permitting full-benefit dual eligible individuals to switch Medicare prescription drug plan under the Medicare prescription drug benefit at any time, for any reason, and improving data flows and communication with plans to ensure that plan switches by such individuals become fully effective as quickly as possible. (F) Partnering with national, State, and local groups that work with full-benefit dual eligible individuals to educate such individuals about the Medicare prescription drug program, and assisting in their transition to, and enrollment under, such program. (b) Sense of the Senate.--It is the sense of the Senate that-- (1) the Secretary of Health and Human Services is making significant progress in smoothing the implementation of the new Medicare prescription drug program, legislation changing the program is not needed at this time, and legislation at this time would also likely complicate implementation of the program and confuse beneficiaries; (2) each of the implementation problems identified under the Medicare prescription drug program will be resolved more quickly through administrative actions, which the Secretary of Health and Human Services already has the authority to take under current law, rather than through Congressional action followed by administrative action; (3) the Senate fully supports the efforts of the Secretary of Health and Human Services, Medicare prescription drug plans, pharmacists, and others to implement the Medicare prescription drug program and to resolve problems that have occurred during the implementation of the program; and (4) the pace of enrollment in the Medicare prescription drug benefit indicates that extending the six-month enrollment period is not warranted at this time, and, by contrast, such an action could exacerbate implementation issues under the program. ______